RESI@TMCx: Medtech Strategics Share Their Insight

9 Jul

By Lucy Parkinson, Senior Research Manager, LSN 

Lastlucy 10*10 month at RESI@TMCx, we gathered together a group of investors from large medical device manufacturers to discuss how they engage with early stage medtech companies. In this panel, investment staff from General Electric, Becton Dickinson, Johnson & Johnson, and Siemens answered wide-ranging questions about engaging with early stage companies, including: What mechanisms do you use to engage with startups? How do you work with accelerators and incubators? Are medtech strategics investing at an earlier stage than they did in the past? How do you approach breakthrough technologies that could disrupt your firm’s existing businesses?

To hear the answers to these questions and many more, watch this RESI video recap.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: